MedPath

Zhejiang Provincial People's Hospital

🇨🇳China
Ownership
-
Established
1978-01-01
Employees
-
Market Cap
-
Website
http://wwwold.hospitalstar.com/

Research and Application of Ultrasonic Intelligent Diagnosis System for Ovarian Mass

Not yet recruiting
Conditions
Ovarian Neoplasms
Adnexal Mass
Interventions
Diagnostic Test: Artificial intelligence model
First Posted Date
2024-07-30
Last Posted Date
2024-07-30
Lead Sponsor
Zhejiang Provincial People's Hospital
Target Recruit Count
100000
Registration Number
NCT06528236

Clinical Study of Cord Blood-Derived CAR-NK Cells in Gastric Cancer and Pancreatic Cancer

Phase 1
Recruiting
Conditions
Gastric Cancer
Pancreas Adenocarcinoma
Interventions
Biological: CB CAR-NK182
First Posted Date
2024-06-18
Last Posted Date
2024-07-31
Lead Sponsor
Zhejiang Provincial People's Hospital
Target Recruit Count
30
Registration Number
NCT06464965
Locations
🇨🇳

Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China

Early Identification of Malignant Brain Edema in laRge Artery oCclusive Stroke After Endovascular Therapy (EMBRACE Study)

Recruiting
Conditions
Brain Edema
Prediction Model
Endovascular Therapy
Ischemic Stroke
First Posted Date
2024-06-11
Last Posted Date
2024-06-11
Lead Sponsor
Zhejiang Provincial People's Hospital
Target Recruit Count
1950
Registration Number
NCT06451887
Locations
🇨🇳

Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China

Evaluate the Efficacy and Safety of Interferon-α Combined With ATO in the Treatment of Arsenic-resistant APL

Not Applicable
Recruiting
Conditions
Tumour
Interventions
First Posted Date
2024-06-10
Last Posted Date
2024-06-10
Lead Sponsor
Zhejiang Provincial People's Hospital
Target Recruit Count
15
Registration Number
NCT06450145
Locations
🇨🇳

First Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang, China

🇨🇳

Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China

Fundus Optical coheRence Tomography Angiography Evaluation for Small-vessel Health in Cerebral Small Vessel Disease

Recruiting
Conditions
Choroid; Injury
Cerebral Small Vessel Diseases
Retinal Ischemia
First Posted Date
2024-05-29
Last Posted Date
2024-05-29
Lead Sponsor
Zhejiang Provincial People's Hospital
Target Recruit Count
2400
Registration Number
NCT06431711
Locations
🇨🇳

Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China

Accuracy of an Artificial Intelligence-assisted Diagnostic System for Caries Diagnosis: a Prospective Multicenter Clinical Study

Not yet recruiting
Conditions
Dental Caries
Artificial Intellegence
Diagnosis
Machine Learning
First Posted Date
2024-05-24
Last Posted Date
2024-07-10
Lead Sponsor
Zhejiang Provincial People's Hospital
Target Recruit Count
220
Registration Number
NCT06428344

Dementia Risk Registry for Young and Middle-aged CSVD Patients in the Next 10 Years

Recruiting
Conditions
Cerebral Small Vessel Diseases
Health Behavior
Health Behavior, Risky
Dementia, Mixed
Interventions
Other: Individuals with CSVD
First Posted Date
2023-12-11
Last Posted Date
2024-02-12
Lead Sponsor
Zhejiang Provincial People's Hospital
Target Recruit Count
1000
Registration Number
NCT06164262
Locations
🇨🇳

Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China

Steroid Diabetes in Patients With Kidney Disease

Recruiting
Conditions
Nephrotic Syndrome
Interventions
Other: no intervention
First Posted Date
2023-12-08
Last Posted Date
2024-04-29
Lead Sponsor
Zhejiang Provincial People's Hospital
Target Recruit Count
300
Registration Number
NCT06161701
Locations
🇨🇳

Zhejiang provincial people's hospital, Hangzhou, Zhejiang, China

Revascularization Effect on CSVD Burden in Carotid Artery Stenosis

Recruiting
Conditions
Carotid Artery Stenosis
Cerebral Small Vessel Diseases
Interventions
Procedure: carotid artery stenting
Drug: drug therapy
First Posted Date
2023-09-11
Last Posted Date
2024-10-11
Lead Sponsor
Zhejiang Provincial People's Hospital
Target Recruit Count
1000
Registration Number
NCT06031610
Locations
🇨🇳

Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China

Evaluating Xihuang Pill to Improve the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer

Not Applicable
Not yet recruiting
Conditions
Breast Cancer
Chemotherapy Effect
Interventions
Drug: Epirubicin, Cyclophosphamide, Xihuang Pill, Docetaxel
Drug: Epirubicin, Cyclophosphamide, Docetaxel
First Posted Date
2023-06-22
Last Posted Date
2023-06-22
Lead Sponsor
Zhejiang Provincial People's Hospital
Target Recruit Count
200
Registration Number
NCT05914753
© Copyright 2025. All Rights Reserved by MedPath